First Time Loading...

Medlive Technology Co Ltd
HKEX:2192

Watchlist Manager
Medlive Technology Co Ltd Logo
Medlive Technology Co Ltd
HKEX:2192
Watchlist
Price: 8.78 HKD 0.69% Market Closed
Updated: May 7, 2024

Medlive Technology Co Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Medlive Technology Co Ltd
Cash from Financing Activities Peer Comparison

Comparables:
Y
2158
300288
300451
300253
Y
301337

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Medlive Technology Co Ltd
HKEX:2192
Cash from Financing Activities
-¥22.4m
CAGR 3-Years
-99%
CAGR 5-Years
-31%
CAGR 10-Years
N/A
Y
Yidu Tech Inc
HKEX:2158
Cash from Financing Activities
¥361.5m
CAGR 3-Years
-16%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Guiyang Longmaster Information & Technology Co Ltd
SZSE:300288
Cash from Financing Activities
-¥14.7m
CAGR 3-Years
49%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B-SOFT Co Ltd
SZSE:300451
Cash from Financing Activities
-¥156.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Winning Health Technology Group Co Ltd
SZSE:300253
Cash from Financing Activities
-¥78m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-26%
Y
Yarward Electronics Shandong Co Ltd
SZSE:301337
Cash from Financing Activities
-¥7.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Medlive Technology Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
-22.4m CNY

Based on the financial report for Dec 31, 2023, Medlive Technology Co Ltd's Cash from Financing Activities amounts to -22.4m CNY.

What is Medlive Technology Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-31%

Over the last year, the Cash from Financing Activities growth was 0%. The average annual Cash from Financing Activities growth rates for Medlive Technology Co Ltd have been -99% over the past three years , -31% over the past five years .